Overview

Impact of Ascorbic Acid in the Prevention of Vancomycin Induced Nephrotoxicty

Status:
Recruiting
Trial end date:
2020-09-01
Target enrollment:
Participant gender:
Summary
A Randomized controlled trial aiming to investigate whether ascorbic acid has a role in preventing vancomycin induced nephrotoxicity or not in critically ill patients.
Phase:
Phase 4
Details
Lead Sponsor:
Ain Shams University
Treatments:
Ascorbic Acid
Vancomycin